Does the CSL share price have a higher share price growth?

The CSL share price has had much higher share price growth. In 2010 to 2012, CSL had similar share price performance with GFRS and BAX. Since 2012, CSL growth accelerated and grew a remarkable 577.92% from 2010 to 2019, compared with 218.46% growth of GFRS and 169.75% growth of BAX.

Why did CSL purchase shares in 2019?

• CSL has a commercial relationship to acquire laboratory supplies from Agilent Technologies, of which Dr Tadataka Yamada KBE is a Director. During 2019, CSL completed two on-market purchases of shares for the purposes of the NED Share Plan and NED Rights Plan.

How did CSL Limited perform in 2023?

[Read more] In 2023, CSL Limited's revenue was $19.59 billion, an increase of 35.36% compared to the previous year's $14.47 billion. Earnings were $3.34 billion, an increase of 7.30%. Data follow the approval of the world's first self-amplifying (sa-mRNA) COVID-19 vaccine for adults in Japan.